General (147) Partnerships (40) New Products (8) Acquisitions (6) New Technologies (4) Financials (3)
Pharma and Biotech (162) Corporate (20) Bioscience (8)
2021 (3) 2020 (42) 2019 (29) 2018 (23) 2017 (21) 2016 (26) 2015 (12) 2014 (6)
English (162)
EnglishX
Showing 141‐160 of 162
results per page
02 Feb 2016
Lonza to Build Capabilities for Drug Product Development Services, Enabling One-Stop-Shop Solutions for Customers
Lonza is entering the field of Drug Product Development Services for customers by building its capabilities step-wise over the coming...
13 Jan 2016
Lonza Expands Single-Use Manufacturing Capacity in Slough (UK) Facility to Meet Customer Demand
Lonza adds two 1000L single-use bioreactor systems to its current mammalian manufacturing capacityThe additional bioreactors will help meet the...
12 Jan 2016
Lonza Further Strengthens QC Insider™ Toolbox with Launch of e-Learning Modules for Endotoxin Testing
Walkersville, MD (USA)/Cologne (DE), 12 January 2016 – Today Lonza released a suite of endotoxin-specific e-Learning Modules for its QC Insider™...
06 Jan 2016
Lonza to Showcase Automation Solutions for Transfection and Endotoxin Testing Technologies at SLAS2016
Walkersville, MD (USA)/Cologne (DE), 6 January 2016 – Lonza announced today that its team will attend SLAS2016, the Fifth Annual International...
02 Dec 2015
Lonza Announces Second Global Endotoxin Testing Summit – and Another Opportunity to “Flip” Crabs
Walkersville, MD (USA), 2 December 2015 – Lonza will host its next Global Endotoxin Testing Summit on 23-25 May 2016 in Annapolis, MD (USA) and...
16 Oct 2015
Lonza to Host Free Webinar on Integrated QC Processes and Data Integrity
Walkersville, MD, USA / Cologne, Germany, 16 October 2015 – Lonza has announced that it will host a free 60-minute webinar on 3 November 2015...
15 Oct 2015
Lonza Authors Recent Publication on Availability of cGMP-Manufactured Human Induced Pluripotent Stem Cells for Pre-Clinical and Clinical Applications
Walkersville, MD (USA), 15 October 2015 – Lonza, a global leader in the field of cell therapy development and manufacturing, announced today the...
07 Oct 2015
Lonza and Benitec Enter Agreement to Develop Scalable AAV Manufacturing Process for ddRNAi Therapeutics
Basel, Switzerland, and Sydney, Australia, 7 October 2015 – Lonza Houston, Inc., a global leader in biological, cell and viral gene therapy...
07 Sep 2015
Lonza Launches Dedicated Hematopoietic and Immune Cells Knowledge Center
07 Jul 2015
Lonza to Expand the Availability of the RAFT™ 3D Cell Culture System
Lonza to Expand the Availability of the RAFT™ 3D Cell Culture System
16 Jun 2015
Lonza to Expand Viral Therapy Business with Planned Construction of New Facility in Houston, TX
Lonza to Expand Viral Therapy Business with Planned Construction of New Facility in Houston, TX
26 May 2015
Lonza to Present New Technologies and Products for Advancing Stem Cell Research and Discovery at ISSCR 2015
Lonza to Present New Technologies and Products for Advancing Stem Cell Research and Discovery at ISSCR 2015
21 May 2015
Lonza Announces Additional Speakers for Next Month’s 1st Global Endotoxin Testing Summit
Lonza Announces Additional Speakers for Next Month’s 1st Global Endotoxin Testing Summit
28 Apr 2015
Lonza Introduces CytoSMART™ System for Walk-Away Live Cell Imaging
Lonza Introduces CytoSMART™ System for Walk-Away Live Cell Imaging
30 Mar 2015
CPI led UK Biotech consortium secures £6.2m government investment
CPI led UK Biotech consortium secures £6.2m government investment
18 Feb 2015
Lonza and arGEN-X Announce a Multi-product GS Xceed™ License Agreement for Therapeutic Antibodies
Lonza and arGEN-X Announce a Multi-product GS Xceed™ License Agreement for Therapeutic Antibodies
10 Dec 2014
Lonza Executes Collaboration Agreements with Two Innovation Clusters
Lonza Executes Collaboration Agreements with Two Innovation Clusters
03 Nov 2014
Lonza and Celladon Corporation Establish a Strategic Commercial Manufacturing Collaboration for MYDICAR®
Lonza and Celladon Corporation Establish a Strategic Commercial Manufacturing Collaboration for MYDICAR®
30 Oct 2014
Bristol-Myers Squibb and Lonza Expand Manufacturing Agreement
Bristol-Myers Squibb and Lonza Expand Manufacturing Agreement
04 Sep 2014
Lonza Introduces Services for Rational Vaccine Design and Development to Help Reduce the Cost of Failure and Increase the Chance of Clinical Success
Lonza Introduces Services for Rational Vaccine Design and Development to Help Reduce the Cost of Failure and Increase the Chance of Clinical Success
< 1 ... 5 6 7 8 9 >